CD274 and breast cancer: RB-loss and RBKO signatures had a correlation of 0.177 (P < 0.0001) and 0.157 (P < 0.0001) with CD274 in mixed BC and a correlation of 0.128 (P = 0.0668) and 0.154 (P = 0.028) in TNBC, respectively.